You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

CLAD+RITU

Cancer Type: Hematologic, Leukemia - Hairy Cell, Lymphoma - Non-Hodgkin's Low Grade      Intent: Palliative
Regimen Category: Evidence-informed
Funding:
New Drug Funding Program
    Rituximab in Combination with Chemotherapy - Indolent B-cell Lymphoma
New Drug Funding Program
    Rituximab - Maintenance Treatment - Lymphoma

You might also be interested in